Compier IRT with Mailbox

Home / Innovation / Compier IRT with Mailbox

Establish an automated AE Intake, Receipt and Triage Capability using Artificial Intelligence

Compier IRT with Mailbox

Compier IRT enables Pharma companies to simplify multi-channel adverse event case intake, receipt, and triaging. The advanced automation capabilities facilitate fast and intelligent case intake from various channels in different data formats. It also has a built-in Inbox for distribution of emails on safety mailbox to different business partners and vendors.

Key Product Features

With a robust multi-channel case intake capability, collect all inbound cases from various channels including web, email, clinical trial portals, mobile app, etc. Cases from social media, literature and HCPs can also be redirected for receipt and triage.

Leverage ready to be deployed automation capabilities through OCR and Artificial Intelligence using NLP/ ML techniques to automatically parse raw source data and create a structured AE case from standard form such as CIOMS or and nonstandard AE Report/Snapshot.

Using the built-in email Inbox, all incoming adverse event cases from multiple stakeholders and sources can be centrally managed without having to use any other external email system. A case can be created directly from inbox with the source attachments after which receipt and triage workflows can be triggered.

Keep a track of all inbound case status and avoid delays in adverse events case processing with automatic process alerts and notifications. Reduce process deviations, quality deficiencies and eliminate compliance shortfall with immediate time-bound email alerts.

All received AEs and their versions can be triaged automatically to downstream drug safety systems using industry data standards such as E2B R2/R3 formats. Industries most used safety databases such as Oracle Argus Safety, Aris Global Lifesphere are seamlessly supported with our Bi-Directional integration.

Compier IRT is available on iOS and Android devices with support of data capture on configurable forms. Solution can also be deployed as a web portal for submission of Adverse Events for intake, review and further processing.

Get insights into operational and intake data with our built-in reporting and analytics module. Our Solution comes with 40 + standard reports and dashboards.

Compier IRT adheres to global compliance such as GxP, HIPAA and EU-GDPR regulations with the setup of country specific data privacy rules. Organization can conduct business operations as per applicable data protection company policies.

Compier IRT is a 21 CFR Part 11 and Annex 11 Compliant solution with a non-editable audit trail and transaction history for all the activities performed in the system.

Technology Image

Solution Benefits for Clients

  • Improve Efficiency and Productivity
  • Improve Adverse Event Data Quality
  • Structure the Unstructured Data with AI
  • Achieve Speed with Automation and Integrations
  • Achieve Global Regulatory Compliance
  • Address Current and Future Business Needs
  • Lower Total Cost of Ownership

How Do we Deliver

Compier IRT with Mailbox is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform such as Case Exchange & Reconciliation, L2A Filter etc.

Latest News / Articles

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us